We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tendon Transfer Shows Promise in Correcting Facial Paralysis

By HospiMedica staff writers
Posted on 07 Aug 2007
Temporalis tendon transfer offers a safe, effective, and simple reconstructive procedure when reinnervation of facial muscles is not an option, a new study claims.

Researchers at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) based this claim on a clinical series of seven consecutive patients. More...
Before surgery, patients underwent comprehensive physical therapy that focused on helping each patient understand how to coordinate individual muscle contraction to produce facial expressions, particularly the smile. The physical therapy resumed after removal of sutures, usually about seven days after surgery. The surgical technique involved both the temporalis muscle and the tendon. The tendon was spread horizontally for 3 to 4 cm and sutured to the perioral musculature and some deep dermis. The reinsertion site for the temporalis tendon was determined on the basis of the dominant musculature in a patient's smile: a more horizontal zygomaticus major insertion versus a more vertical levator labii superioris alaeque nasi insertion.

A minimum of four months after surgery, each patient completed a questionnaire to assess satisfaction with the results. The patients' ratings averaged 8.4 for appearance, 8.1 for feeding, 8.7 for speech, and 7.1 for smile function. Every patient had postsurgical movement, which averaged 4.2 mm at the oral commissure. The only notable complication was a case of postoperative salivary fluid collection that required drainage. Specialists in otolaryngology-head and neck surgery evaluated surgical outcomes on the basis of photographs of the patients. The physicians rated overall outcome as excellent to superb for four patients and good for the other three. The study was published in the July 2007 issue of Archives of Facial and Plastic Surgery.

"Temporalis tendon transfer is a relatively easy procedure to perform that has distinct advantages compared with other forms of facial reanimation and provides very good results. This procedure results in improved form and function, may often be performed in a minimally invasive manner, and eliminates the facial asymmetry typically produced by temporalis transfer,” concluded lead author Patrick Byrne, M.D., and colleagues.


Related Links:
Johns Hopkins University School of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.